SCHEMBL4125043

SCHEMBL4125043

CCC(C)C1CCCCCC1=O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 1/20 0.49
KMT2A Q03164 1/20 0.45
CA1 P00915 2/20 0.42
CA2 P00918 1/20 0.42
CA4 P22748 1/20 0.42
ALDH1A1 P00352 7/20 0.40
POLB P06746 2/20 0.40
CYP3A4 P08684 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
NPC1 O15118 3/20 0.38
RAB9A P51151 3/20 0.38
HPGD P15428 3/20 0.38
KDM4E B2RXH2 2/20 0.38
TP53 P04637 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
GAA P10253 1/20 0.36
SMN1; SMN2 Q16637 2/20 0.35
SHBG P04278 1/20 0.34
MAPT P10636 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28379100 0.98 CYP2D6 (0.50) CYP2D6KMT2ACA1CA2CA4
SCHEMBL87947 0.98 CYP2D6 (0.50) CYP2D6KMT2ACA1CA2CA4
SCHEMBL29107614 0.98 CYP2D6 (0.50) CYP2D6KMT2ACA1CA2CA4
Alcohol SCHEMBL28865888 0.93 CYP2D6 (0.50) CYP2D6KMT2ACA1CA2CA4
SCHEMBL13104108 0.92 CYP2D6 (0.44) CYP2D6KMT2ACA1CA2CA4
SCHEMBL10453942 0.92 CYP2D6 (0.44) CYP2D6KMT2ACA1CA2CA4
SCHEMBL4740930 0.85 CYP2D6 (0.43) CYP2D6KMT2ACA1CA2CA4
SCHEMBL28383147 0.84 CYP2D6 (0.44) CYP2D6KMT2ACA1CA2CA4
SCHEMBL15577104 0.83 CYP2D6 (0.44) CYP2D6KMT2ACA1CA2CA4
SCHEMBL3726325 0.83 CYP2D6 (0.44) CYP2D6KMT2ACA1CA2CA4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8436005-B2 Macrocyclic pyrimidine derivatives ABBOTT LABORATORIES (US) 2013-05-07 US disclosed
US-20090253678-A1 MACROCYCLIC PYRIMIDINE DERIVATIVES ABBOTT LABORATORIES (US) 2009-10-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090253678-A1 MACROCYCLIC PYRIMIDINE DERIVATIVES DPYD, TYMS, TYMP CYP2D6 950/4885KMT2A 2893/4885CA1 4806/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.